HomeBGLC • NASDAQ
add
BioNexus Gene Lab Corp
Previous close
$0.29
Day range
$0.29 - $0.31
Year range
$0.28 - $3.39
Market cap
5.27M USD
Avg Volume
83.98K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 2.63M | 3.00% |
Operating expense | 1.66M | -42.27% |
Net income | -1.35M | 48.44% |
Net profit margin | -51.15 | 49.94% |
Earnings per share | — | — |
EBITDA | -1.30M | 48.01% |
Effective tax rate | -0.12% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.14M | -32.69% |
Total assets | 11.00M | -4.10% |
Total liabilities | 1.61M | -9.61% |
Total equity | 9.39M | — |
Shares outstanding | 17.97M | — |
Price to book | 0.56 | — |
Return on assets | -30.22% | — |
Return on capital | -34.07% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -1.35M | 48.44% |
Cash from operations | -1.46M | -62.29% |
Cash from investing | -183.12K | 49.23% |
Cash from financing | -199.41K | -103.47% |
Net change in cash | -1.28M | -129.10% |
Free cash flow | -1.25M | -110.18% |
About
Founded
2017
Website
Employees
30
